To date, epidemiological studies have assessed the association between Toll-like receptor 2 (TLR2) gene polymorphisms and cancer risk. However, the results of these studies remain controversial. We aimed to examine the associations between three SNPs (Delta22, rs3804099 and rs3804100) of TLR2 gene and cancer risk by conducting a meta-analysis of case-control studies. A total of eight studies eligible for TLR2 Delta22 polymorphism (2,061 cancer cases and 3,490 controls), six studies for rs3804099 polymorphism (1,681 cases and 1,996 controls), and five studies for rs3804100 polymorphism (3,131 cases and 2,969 controls) were included in this meta-analysis. Our results suggested that Delta22 represented a risk factor on cancers (del-allele versus ins-allele, OR=1.35, 95% CI: 1.05-1.72; del/del versus ins/ins, OR=1.91, 95% CI: 1.03-3.56; del/del + del/ins versus ins/ins, OR=1.33, 95% CI: 1.02-1.73; del/del versus del/ins + ins/ins, OR=1.79, 95% CI: 1.02-3.13), especially in Caucasian population and among population-based studies. For TLR2 rs3804099 polymorphism, we found a decreased cancer risk associated with CC/CT genotype only in Asians compared with TT genotype. TLR2 rs3804100 polymorphism was significantly associated with an elevated cancer risk in overall analysis (CC versus CT, OR=1.70, 95% CI: 1.20-2.42; CC versus CT/TT, OR=1.61, 95% CI: 1.15-2.25). In a stratified analysis, a statistically significant correlation was also observed in non-Caucasian population and population-based studies. In conclusion, the Delta22 and rs3804100 polymorphisms in TLR2 are risk factors for cancer susceptibility while the TLR2 rs3804099 dominant genotype is a protective factor, especially in Asians. Further large and well-designed studies are needed to confirm these conclusions.
Cancer is a major public health problem worldwide. It is a multistep process resulting from complex interactions between genetic and environmental factors [1] . Host genetic factors may play a critical role in the pathophysiology of many human cancers [2] . The genetic susceptibility to cancer is multifactorial, with some factors known to function in the cell cycle, apoptosis, or cell differentiation. In addition, the risk may also comprise additional factors that are related to the activation of the immune system and inflammation. Consequently, common single nucleotide polymorphisms (SNPs) of a series of low penetrance alleles, modified during the above-mentioned processes, are likely to play an important role in cancer susceptibility.
Toll-like receptors (TLRs) constitute a family of receptors directly recognizing a wide spectrum of exogenous and endogenous ligands playing the key role in realization of innate and adaptive immune response, and participating in the processes of cell proliferation, survival, apoptosis, angiogenesis, tissue remodeling and repair [3] [4] [5] . There are 10 TLRs expressed in human beings [6] , and Toll-like receptor 2 (TLR2) is one of the most actively investigated TLRs. Dysregulation of the TLR2 signaling owing to SNPs may shift balance between pro-and anti-inflammatory cytokines, modulating the risk of infection, chronic inflammation and cancer. The human TLR2 gene is located on chromosome 4q32 and is composed of 2 non-coding exons and 1coding exon [7] . Genetic studies on the TLR2 gene have identified a number of polymorphisms which have been shown to affect host defense and disease progression [8, 9] . A 22-bp nucleotide deletion at position -196 to -174 of the untranslated 5'-region is associated with reduced TLR2 transcriptional activity compared to the wild type allele in luciferase reporter assays [10] . This polymorphism has already been shown to be associated with an increased risk of noncardiac gastric cancer and susceptibility to cervical cancer [11, 12] . Another 2 polymorphisms within the TLR2 exon region, namely, it has been reported, that TLR2 rs3804099 T/C and rs3804100 T/C can alter the risk of hepatocellular carcinoma development [13] .
Despite a series of molecular epidemiological studies aiming to examine the association between these three polymorphisms and the susceptibility of different cancer types, the available results remain conflicting. Therefore, it is highly necessary to perform a quantitative and systematic investigation with rigorous methods. To further evaluate the association between TLR2 polymorphisms (-196 to 174 del/ins, rs3804099 and rs3804100) and the risk of cancer, a meta-analysis was conducted on all eligible published studies in current study.
Materials and methods
Literature search and data extraction. PubMed, Embase, China National Knowledge Infrastructure, and Chinese Biomedicine Database were searched (the last search update was October 20, 2012) using the following query: ('toll-like receptor 2' or 'TLR2') and ('cancer' or 'tumor' or 'neoplasm' or 'malignancy' or 'carcinoma') and 'polymorphism' by two independent investigators (XP Wang and J Li). All published papers without language restrictions matching the eligible criteria were retrieved. Additional studies were identified by a manual search of references of original or review articles on this topic. Studies included in our meta-analysis have to meet the following criteria: (a) evaluated the relationship of the TLR2 polymorphisms TLR2 -196 to 174 del/ins (Delta22) or rs3804099 or rs3804100 and cancer risk; (b) in a case-control study design; (c) contained available genotype frequency; (d) excluded benign tumors, precancerous lesions. Major reasons for exclusion of studies were (a) only case population; (b) the study did not have the outcomes of comparison reported or it was not possible to determine them; (c) duplicate of previous publication.
Data extraction. Two of the authors (XP Wang and W Xie) extracted all data independently using a standardized extraction form and reached a consensus on all items. In the present study, the following information was extracted: first author, year of publication, country, ethnicity, cancer type, numbers of cases and controls, source of control groups (population-or hospital-based controls), genotyping methods and evidence of Hardy-Weinberg equilibrium (HWE). Meanwhile, gastric cancer was regarded as an independent cancer type in Delta22 analysis; cervical cancer, gallbladder cancer, prostate cancer and hepatocellular carcinoma were merged into the "other cancers" group.
Statistical analysis. Firstly, the strength of the association between the TLR2 polymorphisms (Delta22, rs3804099 and rs3804100) and cancer risk was measured by ORs with 95% confidence intervals (CIs). The statistical significance of the OR was determined using the Z test. Statistical heterogeneity between studies was assessed with the χ 2 -based Q test and I 2 , heterogeneity was considered significant when P<0.05, and I 2 was used to quality variation in OR attributable to heterogeneity. When heterogeneity was not an issue, fixed effect model with Mantel-Haenszel method was used [14] . Otherwise, a random effect model with inverse variance method was used. Generally, we first evaluated the risks of variant allele versus wild-type allele (del-allele vs. ins-allele for Delta22; C allele vs. T allele for rs3804099 and rs3804100). As to genotype comparison, the risks of the heterozygote and variant homozygote compared with the wild-type homozygote was estimated (del/ins vs. ins/ins and del/del vs. ins/ins for Delta22; CT vs. TT and CC vs. TT for rs3804099 and rs3804100), respectively. Then we evaluated the risks of the dominant and recessive effects of the variant allele (del/del + del/ins vs. ins/ins and del/del vs. del/ins + ins/ins for Delta22; CC+CT vs. TT and CC vs. CT+TT for rs3804099 and rs3804100), respectively. In addition, we also performed stratification analyses on cancer type (divided into gastric cancer and other cancers for TLR2 Delta22) and ethnicity, as well as source of control. Publication bias was tested graphically by using funnels plots, in which the standard error was plotted against the log (OR) to form a simple scatter plot, and the funnel plot asymmetry was assessed by the method of Egger's test. Asymmetric plots could indicate potential existing publication bias. The statistical analyses were performed using Stata Statistical package (version 11.0; Stata Corp., College Station, TX) and Review Manager (Version 4.2, the Cochrane Collaboration). All P values were two-sided.
Results
Characteristics of studies. According to the searching strategy, 58 papers were found. We reviewed the titles, abstracts and the full texts of all retrieved articles through defined criteria. Finally, 15 studies including a total of 5,443 cancer cases and 6,793 controls were selected in our meta-analysis [11] [12] [13] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] (Figure 1 ). The characteristics of the selected studies are listed in Table 1 . Among these studies, Delta22 polymorphism was investigated in eight studies with 2061 cases and 3490 controls, whereas six studies were included into rs3804099 polymorphism analysis, with 1681 cases and 1996 controls and five studies into rs3804100 polymorphism analysis, with 3131 cases and 2969 controls. The distribution of genotypes in the controls was consistent with the HardyWeinberg equilibrium for all selected studies, except for two studies [20, 26] for rs3804099 polymorphism.
Meta-analysis. The evaluation of the association between these three polymorphisms and cancer risk is presented in Figure 2) . In a stratified analysis by specific cancer type, no association was found among studies of gastric cancer in all genetic models. However, a significant association was found in other cancer types. In the subgroup analysis by ethnicity, Delta22 polymorphism had a significant increased risk of cancer in Caucasian population in all genetic models (del-allele versus ins-allele, OR=1.97, 95% CI: 1. Table 2 ), but not in Asian population. Meanwhile, in the stratified analysis by source of controls, we found elevated risk among studies from population-based controls in all genetic models.
For rs3804099 polymorphism, in the overall analysis, no association was found in any genetic models (data not shown). In the stratified analysis by ethnicity, we found a decreased Table 2) . When evaluating the effect of the polymorphism by different source of control, we found that rs3804100 significantly increased cancer risk in heterozygous comparison and recessive model among population-based studies. Because of the inadequate sample populations available for Asian and mixed groups, different ethnicities were categorized as Caucasian and non-Caucasian. We also performed sub-analysis stratified by ethnicity and found that rs3804100 polymorphism increased the cancer risk in non-Caucasians.
Sensitivity analyses and publication bias. Sensitivity analysis excluding two studies [20, 26] (for rs3804099 polymorphism) that did not reach HWE in control group, the estimated pooled OR still did not change the results appreciably, indicated that the final results of this meta-analysis were relatively stable and reliable. Begg's and Egger's test were conducted to evaluate publication bias. These different test methods have come to the same conclusion. Both of them revealed no statistical significance for publication bias in all comparison models in this meta-analysis, and the results were shown in Figure 3 and Table 3 .
Discussion
Toll-like receptors (TLRs) are involved in innate immunity defence against microorganisms. The ability to properly re- Figure 3 spond to TLR ligands may be impaired by SNPs within TLR genes, causing an altered susceptibility to disease. Aberrant signaling in TLR pathway activation is involved in the pathogenesis of autoimmune, chronic inflammatory, infectious diseases [6, 27] , and even more seriously involved in cancers. Among TLRs, TLR2 is a central player in response to infection by Gram-positive bacteria and thus an important candidate inflammatory gene. The importance of TLR2 polymorphisms' impact on multiple types of cancer has been a concern in recent years; the most intensively concerned ones are Delta22, rs3804099 and rs3804100, however, the existing data were contradictory. Hence, it is necessary to provide a quantitative approach for combining the results of various studies, and for estimating and explaining their diversity. To the best of our knowledge, this is the first meta-analysis associating TLR2 polymorphisms with cancer risk.
We specifically conducted a systematic search of the literatures and combined the available results concerning on these three potentially functional TLR2 polymorphisms for elucidating genetic factors in cancer. Finally, the present metaanalysis included a total 5,443 cancer cases and 6,793 controls from 15 case-control studies. In the overall analysis, significant association was observed between cancer risk and the variant genotypes of TLR2 Delta22 and rs3804100 polymorphism in different genetic models, however, no association was found in any genetic models of rs3804099 polymorphism. Despite a noteworthy risk effect, the association studies on Delta22 and rs3804100 polymorphism and cancer risk were relatively limited (8 studies for Delta22; 5 studies for rs3804100). In the future study, Delta22 and rs3804100 should be paid far more attention as a most interesting TLR2 polymorphism.
As to the cancer-subgroup analyses, our results suggested that Delta22 was a risk effect on other cancer types but not on gastric cancer. The role of the TLR2 Delta22 polymorphisms in genetic susceptibility to gastric cancer has been intensively investigated. Unexpectedly, data obtained from these studies [12, 17, 21, 23] are contradictory. According to the investigation of Noguchi et al. [10] , the del allele of the indicated SNP reduced the transcriptional activity of the TLR2 gene, and, because the TLR2-mediated immune response is important for the response against Helicobacter pylori (HP) infection [28] , it may be associated with increased risk of such infection and with severe HP-related disease. Thus, it is interesting that this polymorphism was not associated with the risk of HP infection. Possible explanations may include the following: (i) a different prevalence of HP infection in study samples can occur even in the same population if it is large, like the Japanese population (Delta22 may be associated with higher cancer risk only or more strongly in the presence of HP because it correlates with the outcome of HP infection but does not correlate with the risk of such infection); (ii) Tahara et al. [12] recruited patients with noncardia gastric cancer only, and Hishida et al. [17] recruited cases with all types of gastric cancer, which could lead to discrepancies in the results of these 2 studies because the role of HP infection in the etiology of cardia gastric cancer is less significant than in the case with noncardia gastric cancer, according to many studies [29, 30] ; and (iii) chance or any unknown bacterial, host, or environmental factor. It is also possible that this SNP is associated with the risk of gastric cancer independently of HP infection, which is partially proven by the results of Tahara et al. [12] , and other bacteria or endogenous ligands (possibly damage associated molecular patterns such as heat shock proteins or extracellular matrix fragments) may also play a role in a correlation with gastric cancer risk. In addition, the del allele of the Delta22 polymorphism correlated with a higher gallbladder cancer risk in the study of Srivastava et al. [18] and with increased cervical cancer risk in the study of Pandey et al. [11] . This SNP seems to be significantly associated with the risk of many cancer types, which was partially consistent with our present analysis results. However, what plays a major role in this risk-modulating effect/impairment of TLR2-mediated immune response to pathogen-associated molecular patterns or certain alterations in TLR2-endogenous ligands interaction is unclear.
Different ethnicities may have different genetic backgrounds, which influence the association between polymorphism and cancer susceptibility. We also conducted stratified analysis by ethnicity, positive relationship between Delta22 and cancer risk was found in Caucasian population. Meanwhile, we found rs3804100 polymorphism increased cancer risk in non-Caucasian population. However, the sub-analysis of rs3804099 revealed a decreased risk of cancer in Asian population. There are significant geographic and ethnic differences in the intercontinental incidence of Delta22, rs3804099 and rs3804100 polymorphisms. The ethnic differences in the allele frequencies may be a result of natural selection, or balance to other related genetic variants. So, further investigations are warranted to validate ethnic difference in the effect of these functional polymorphisms on cancer risk especially in Asians and Caucasians in the future.
Our results indicated that all genetic models of Delta22 and CC versus CT, as well as CC versus CT/TT genotypes of rs3804100 increased cancer risk among population-based studies but not among hospital-based studies. This reason may be that hospital-based studies have a high risk of producing unreliable results because hospital-based controls may not always be truly representative of the general population. Therefore, a methodologically preferable design, such as using a proper and representative population-based study, is crucial to avoid selection bias.
Some limitations of the present meta-analysis should be addressed. First, the controls were not uniformly defined. Both healthy individuals and patients without cancers in hospital were included in the control group. Thus, the controls may not always be truly representative in the underlying source populations, especially when the polymorphism is also expected to affect the risk of other diseases. Second, the lack of the original data on genotypes and environmental risk factors of the included studies limited our evaluation on the potential gene-environment interaction. Third, our meta-analysis was based on unadjusted estimates, adjusted ORs for age and sex ought to be pooled to provide exact summary estimates if more individual data of studies are available.
In conclusion, this meta-analysis provided evidence of the association between the TLR2 Delta22, rs3804099 and rs3804100 polymorphisms and cancer risk, especially in Caucasians and Asians. However, further large, well-designed, comprehensive studies in various populations; with more detailed individual data are needed to confirm our results. Moreover, to have a better, in-depth understanding of the association between TLR2 polymorphisms and cancer risk, sophisticated gene-gene and gene-environment interactions should also be considered in future analysis.
